Kevin Doody - Jan 15, 2022 Form 4 Insider Report for INVO Bioscience, Inc. (INVO)

Role
Medical Director, Director
Signature
/s/ Kevin Doody
Stock symbol
INVO
Transactions as of
Jan 15, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 08:29 PM
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Award $0 +7.48K +4.4% $0.00 177K Jan 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INVO Stock Option Award $0 +9.09K $0.00 9.09K Jan 15, 2022 Common Stock 9.09K $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in monthly increments over a period of twelve months from the date of grant.